Authors: Schroeder, MC Hamby, JM Connolly, CJC Grohar, PJ Winters, RT Barvian, MR Moore, CW Boushelle, SL Crean, SM Kraker, AJ Driscoll, DL Vincent, PW Elliott, WL Lu, GH Batley, BL Dahring, TK Major, TC Panek, RL Doherty, AM Showalter, HDH

Citation: Mc. Schroeder et al., Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity, J MED CHEM, 44(12), 2001, pp. 1915-1926

Authors: Smaill, JB Palmer, BD Rewcastle, GW Denny, WA McNamara, DJ Dobrusin, EM Bridges, AJ Zhou, HR Showalter, HDH Winters, RT Leopold, WR Fry, DW Nelson, JM Slintak, V Elliot, WL Roberts, BJ Vincent, PW Patmore, SJ

Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 15. 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[d] pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor, J MED CHEM, 42(10), 1999, pp. 1803-1815

Authors: Palmer, BD Smaill, JB Boyd, M Boschelli, DH Doherty, AM Hamby, JM Khatana, SS Kramer, JB Kraker, AJ Panek, RL Lu, GH Dahring, TK Winters, RT Showalter, HDH Denny, WA

Citation: Bd. Palmer et al., Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor, J MED CHEM, 41(27), 1998, pp. 5457-5465